Concentrations of Brain Natriuretic Peptide In Treated Congestive Heart Failure
To the Editor:
We describe here a significant decrease in brain natriuretic peptide (BNP) concentrations in plasma in seven patients after treatment for congestive heart failure (CHF). We studied five men and two women, ages 35-79 (63.8±5.1, mean±SE) years. Six patients (A, B, C, D, E, and F in Figure 1 ) had CHF of class IV, classified by New York Heart Association (NYHA) functional criteria; one patient (G) was in class ifi.
BNP concentration in plasma from each patient was measured by a newly developed radioimmunoassay.
In this RIA, the minimum detectable amount of BNP was 0.3 pg/tube, and the cross-reactivity with a-atrial natriuretic peptide (a-ANP), the amino acid sequence of which is remarkably homologous to BNP (1), was <0.001%. The mean concentration of plasma BNP in the seven patients at the start of treatment was 168.3 (SE 67.8) ngfL, which was about 29-fold higher than that of normal subjects: 5.9 (SE 0.8) ng/L (n = 5). These results are consistent with those of a recent report in which the plasma concentration of BNP in CHF patients markedly increased (2) .
As shown in Figure 1 , after treatment with conventional medication We report here a case of analbuminuric proteinuria that differs from other reported cases (1, 2). The patient, a 68-year-old man admitted to the hospital with unstable angina, had a history of diabetes mellitus, hypertension, and coronary artery disease. He As is well known, BCG methods for measuring albumin in plasma do not always give accurate results, particularly for samples with a low albumin! globulin ratio, as in nephrotic syndrome, burns, and infiammations (2-4). The inaccuracy is particularly significant in methods involving long reaction times (>30 s). The Ektachem BCG-slide method has a reaction time of -460 s, but was reported to yield satisfactory results in a pediatric population (5), and correlated well with a "fast reading" BCG method (6).
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To verify our initial results, we analyzed a further 72 samples, selected to have albumin concentrations ranging from 10 to 50 g/L, and albumin! globulin ratios ranging from 0.26 to 2.5. We measured albumin concentrations with a rate immunonephelometric method (ICS; Beckman Instruments, Mijdrecht, The Netherlands), and compared these concentrations with those obtained with a BCP method (7) in routine use on a Hitachi
